681 related articles for article (PubMed ID: 11527957)
21. Altered expression of genes related to blood-retina barrier disruption in streptozotocin-induced diabetes.
Klaassen I; Hughes JM; Vogels IM; Schalkwijk CG; Van Noorden CJ; Schlingemann RO
Exp Eye Res; 2009 Jun; 89(1):4-15. PubMed ID: 19284967
[TBL] [Abstract][Full Text] [Related]
22. Integrin-mediated neutrophil adhesion and retinal leukostasis in diabetes.
Barouch FC; Miyamoto K; Allport JR; Fujita K; Bursell SE; Aiello LP; Luscinskas FW; Adamis AP
Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1153-8. PubMed ID: 10752954
[TBL] [Abstract][Full Text] [Related]
23. Characterization of azurocidin as a permeability factor in the retina: involvement in VEGF-induced and early diabetic blood-retinal barrier breakdown.
Skondra D; Noda K; Almulki L; Tayyari F; Frimmel S; Nakazawa T; Kim IK; Zandi S; Thomas KL; Miller JW; Gragoudas ES; Hafezi-Moghadam A
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):726-31. PubMed ID: 18235021
[TBL] [Abstract][Full Text] [Related]
24. Aldose reductase inhibitor fidarestat attenuates leukocyte-endothelial interactions in experimental diabetic rat retina in vivo.
Hattori T; Matsubara A; Taniguchi K; Ogura Y
Curr Eye Res; 2010 Feb; 35(2):146-54. PubMed ID: 20136425
[TBL] [Abstract][Full Text] [Related]
25. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy.
Amin RH; Frank RN; Kennedy A; Eliott D; Puklin JE; Abrams GW
Invest Ophthalmol Vis Sci; 1997 Jan; 38(1):36-47. PubMed ID: 9008628
[TBL] [Abstract][Full Text] [Related]
26. VEGF activation of protein kinase C stimulates occludin phosphorylation and contributes to endothelial permeability.
Harhaj NS; Felinski EA; Wolpert EB; Sundstrom JM; Gardner TW; Antonetti DA
Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):5106-15. PubMed ID: 17065532
[TBL] [Abstract][Full Text] [Related]
27. Altered expression patterns of VEGF receptors in human diabetic retina and in experimental VEGF-induced retinopathy in monkey.
Witmer AN; Blaauwgeers HG; Weich HA; Alitalo K; Vrensen GF; Schlingemann RO
Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):849-57. PubMed ID: 11867607
[TBL] [Abstract][Full Text] [Related]
28. Endostatin modulates VEGF-mediated barrier dysfunction in the retinal microvascular endothelium.
Brankin B; Campbell M; Canning P; Gardiner TA; Stitt AW
Exp Eye Res; 2005 Jul; 81(1):22-31. PubMed ID: 15978251
[TBL] [Abstract][Full Text] [Related]
29. Effects of angiotensin-converting enzyme inhibitors and beta-adrenergic blockers on retinal vascular endothelial growth factor expression in rat diabetic retinopathy.
Zheng Z; Chen H; Xu X; Li C; Gu Q
Exp Eye Res; 2007 Apr; 84(4):745-52. PubMed ID: 17303121
[TBL] [Abstract][Full Text] [Related]
30. A novel nonradioactive method to evaluate vascular barrier breakdown and leakage.
Trichonas G; Manola A; Morizane Y; Thanos A; Koufomichali X; Papakostas TD; Montezuma S; Young L; Miller JW; Gragoudas E; Vavvas D
Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1677-82. PubMed ID: 19875655
[TBL] [Abstract][Full Text] [Related]
31. VEGF increases retinal vascular ICAM-1 expression in vivo.
Lu M; Perez VL; Ma N; Miyamoto K; Peng HB; Liao JK; Adamis AP
Invest Ophthalmol Vis Sci; 1999 Jul; 40(8):1808-12. PubMed ID: 10393052
[TBL] [Abstract][Full Text] [Related]
32. Aquaporin 4 knockdown exacerbates streptozotocin-induced diabetic retinopathy through aggravating inflammatory response.
Cui B; Sun JH; Xiang FF; Liu L; Li WJ
Exp Eye Res; 2012 May; 98():37-43. PubMed ID: 22449442
[TBL] [Abstract][Full Text] [Related]
33. VEGF-A induced hyperpermeability of blood-retinal barrier endothelium in vivo is predominantly associated with pinocytotic vesicular transport and not with formation of fenestrations. Vascular endothelial growth factor-A.
Hofman P; Blaauwgeers HG; Tolentino MJ; Adamis AP; Nunes Cardozo BJ; Vrensen GF; Schlingemann RO
Curr Eye Res; 2000 Aug; 21(2):637-45. PubMed ID: 11148600
[TBL] [Abstract][Full Text] [Related]
34. VEGF-TRAP(R1R2) suppresses choroidal neovascularization and VEGF-induced breakdown of the blood-retinal barrier.
Saishin Y; Saishin Y; Takahashi K; Lima e Silva R; Hylton D; Rudge JS; Wiegand SJ; Campochiaro PA
J Cell Physiol; 2003 May; 195(2):241-8. PubMed ID: 12652651
[TBL] [Abstract][Full Text] [Related]
35. Protective effects of a coumarin derivative in diabetic rats.
Bucolo C; Ward KW; Mazzon E; Cuzzocrea S; Drago F
Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3846-52. PubMed ID: 19279317
[TBL] [Abstract][Full Text] [Related]
36. Vascular endothelial growth factor in diabetes induced early retinal abnormalities.
Cukiernik M; Hileeto D; Evans T; Mukherjee S; Downey D; Chakrabarti S
Diabetes Res Clin Pract; 2004 Sep; 65(3):197-208. PubMed ID: 15331199
[TBL] [Abstract][Full Text] [Related]
37. Baicalein reduces inflammatory process in a rodent model of diabetic retinopathy.
Yang LP; Sun HL; Wu LM; Guo XJ; Dou HL; Tso MO; Zhao L; Li SM
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2319-27. PubMed ID: 19011009
[TBL] [Abstract][Full Text] [Related]
38. Rat strain-dependent susceptibility to ischemia-induced retinopathy associated with retinal vascular endothelial growth factor regulation.
Lu K; Zhou Y; Kaufman K; Mott R; Ma JX
J Mol Endocrinol; 2007 Apr; 38(4):423-32. PubMed ID: 17446232
[TBL] [Abstract][Full Text] [Related]
39. Enhancement of glucose transport by vascular endothelial growth factor in retinal endothelial cells.
Sone H; Deo BK; Kumagai AK
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1876-84. PubMed ID: 10845612
[TBL] [Abstract][Full Text] [Related]
40. Protective effect of clusterin on blood-retinal barrier breakdown in diabetic retinopathy.
Kim JH; Kim JH; Yu YS; Min BH; Kim KW
Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1659-65. PubMed ID: 19875648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
